Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil.

Campi-Azevedo AC, Peruhype-Magalhāes V, Coelho-Dos-Reis JG, Antonelli LR, Costa-Pereira C, Speziali E, Reis LR, Lemos JA, Ribeiro JGL, Bastos Camacho LA, de Sousa Maia ML, Barbosa de Lima SM, Simões M, de Menezes Martins R, Homma A, Cota Malaquias LC, Tauil PL, Costa Vasconcelos PF, Martins Romano AP, Domingues CM, Teixeira-Carvalho A, Martins-Filho OA; Collaborative Group for Studies of Yellow Fever Vaccine.

Emerg Infect Dis. 2019 Aug;25(8):1511-1521. doi: 10.3201/eid2508.181432. Epub 2019 Aug 17.

PMID:
31298654
Free Article
2.

Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine.

da Costa-Rocha IA, Campi-Azevedo AC, Peruhype-Magalhães V, Coelho-Dos-Reis JG, Fradico JRB, Souza-Lopes T, Reis LR, Freire LC, Costa-Pereira C, Mambrini JVM, Maia MLS, de Lima SMB, de Noronha TG, Xavier JR, Camacho LAB, de Albuquerque EM, Farias RHG, de Castro TDM, Homma A, Romano APM, Domingues CM, Martins RM, Teixeira-Carvalho A, Martins-Filho OA.

Front Immunol. 2019 Jun 21;10:1211. doi: 10.3389/fimmu.2019.01211. eCollection 2019.

PMID:
31293563
Free PMC Article
3.

Impact of synthetic and biological immunomodulatory therapy on the duration of 17DD yellow fever vaccine-induced immunity in rheumatoid arthritis.

Ferreira CC, Campi-Azevedo AC, Peruhype-Magalhāes V, Coelho-Dos-Reis JG, Antonelli LRDV, Torres K, Freire LC, da Costa-Rocha IA, Oliveira ACV, Maia MLS, de Lima SMB, Domingues CM, Teixeira-Carvalho A, Martins-Filho OA, da Mota LMH; Collaborative Group for Studies of Yellow Fever Vaccine.

Arthritis Res Ther. 2019 Mar 14;21(1):75. doi: 10.1186/s13075-019-1854-6.

4.

Mannosyltransferase (GPI-14) overexpression protects promastigote and amastigote forms of Leishmania braziliensis against trivalent antimony.

Ribeiro CV, Rocha BFB, Moreira DS, Peruhype-Magalhães V, Murta SMF.

Parasit Vectors. 2019 Jan 25;12(1):60. doi: 10.1186/s13071-019-3305-2.

5.

Phenotypic and functional features of innate and adaptive immunity as putative biomarkers for clinical status and leprosy reactions.

Carvalho JC, Araújo MG, Coelho-Dos-Reis JGA, Peruhype-Magalhães V, Alvares CC, Moreira ML, Teixeira-Carvalho A, Martins-Filho OA, Araújo MSS.

Microb Pathog. 2018 Dec;125:230-239. doi: 10.1016/j.micpath.2018.09.011. Epub 2018 Sep 7.

PMID:
30195647
6.

Fcγ-RI, Fcγ-RII and IL-10 as predictive biomarkers for post-therapeutic cicatrization time in monocytes from cutaneous leishmaniasis patients.

Rodrigues-Alves ML, Melo-Júnior OAO, Coelho-Dos-Reis JG, Pascoal-Xavier MA, Alves-Costa H, Reis CA, Dutra WO, Silva RE, Senna MCR, Faria AC, Medeiros NI, Gomes JAS, Silveira-Lemos D, Martins-Filho OA, Teixeira-Carvalho A, Costa-Silva MF, Giunchetti RC, Peruhype-Magalhães V.

Parasite Immunol. 2018 Aug;40(8):e12565. doi: 10.1111/pim.12565. Epub 2018 Jul 8.

PMID:
29908029
7.

Multi-parameter approach to evaluate the timing of memory status after 17DD-YF primary vaccination.

Costa-Pereira C, Campi-Azevedo AC, Coelho-Dos-Reis JG, Peruhype-Magalhães V, Araújo MSS, do Vale Antonelli LR, Fonseca CT, Lemos JA, Malaquias LCC, de Souza Gomes M, Rodrigues Amaral L, Rios M, Chancey C, Persi HR, Pereira JM, de Sousa Maia ML, Freire MDS, Martins RM, Homma A, Simões M, Yamamura AY, Farias RHG, Romano APM, Domingues CM, Tauil PL, Vasconcelos PFC, Caldas IR, Camacho LA, Teixeira-Carvalho A, Martins-Filho OA.

PLoS Negl Trop Dis. 2018 Jun 7;12(6):e0006462. doi: 10.1371/journal.pntd.0006462. eCollection 2018 Jun.

8.

Usefulness of FC-TRIPLEX Chagas/Leish IgG1 as confirmatory assay for non-negative results in blood bank screening of Chagas disease.

Campos FMF, Repoles LC, de Araújo FF, Peruhype-Magalhães V, Xavier MAP, Sabino EC, de Freitas Carneiro Proietti AB, Andrade MC, Teixeira-Carvalho A, Martins-Filho OA, Gontijo CMF.

J Immunol Methods. 2018 Apr;455:34-40. doi: 10.1016/j.jim.2018.01.006. Epub 2018 Jan 31.

PMID:
29395166
9.

Infection of hematopoietic stem cells by Leishmania infantum increases erythropoiesis and alters the phenotypic and functional profiles of progeny.

Carvalho-Gontijo R, Moreira DR, Resende M, Costa-Silva MF, Peruhype-Magalhães V, Ribeiro CMF, Ribeiro DD, Silvestre R, Cordeiro-da-Silva A, Martins-Filho OA, Teixeira-Carvalho A.

Cell Immunol. 2018 Apr;326:77-85. doi: 10.1016/j.cellimm.2017.10.016. Epub 2017 Nov 7.

PMID:
29248120
10.

The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences.

Ferreira CC, Campi-Azevedo AC, Peruhype-Magalhāes V, Costa-Pereira C, Albuquerque CP, Muniz LF, Yokoy de Souza T, Oliveira ACV, Martins-Filho OA, da Mota LMH.

Expert Rev Vaccines. 2018 Jan;17(1):79-90. doi: 10.1080/14760584.2018.1406800. Epub 2017 Nov 27. Review.

PMID:
29172832
11.

Distinct patterns of cellular immune response elicited by influenza non-adjuvanted and AS03-adjuvanted monovalent H1N1(pdm09) vaccine.

Giarola-Silva S, Coelho-Dos-Reis JGA, Mourão MM, Campi-Azevedo AC, Nakagaki Silva EE, Luiza-Silva M, Martins MA, Silveira-Cassette ACO, Batista MA, Peruhype-Magalhães V, Antonelli LRDV, Leite Ribeiro JG, Elói-Santos SM, Machado AV, Teixeira-Carvalho A, Martins-Filho OA, Araújo MSS.

Antiviral Res. 2017 Aug;144:70-82. doi: 10.1016/j.antiviral.2017.05.009. Epub 2017 May 23.

PMID:
28549970
12.

MAIT-cells: A tailor-made mate in the ancient battle against infectious diseases?

Moreira ML, Tsuji M, Corbett AJ, Araújo MSS, Teixeira-Carvalho A, Martins-Filho OA, Peruhype-Magalhães V, Coelho-Dos-Reis JG.

Immunol Lett. 2017 Jul;187:53-60. doi: 10.1016/j.imlet.2017.05.007. Epub 2017 May 16. Review.

PMID:
28526582
13.

Heparin removal by ecteola-cellulose pre-treatment enables the use of plasma samples for accurate measurement of anti-Yellow fever virus neutralizing antibodies.

Campi-Azevedo AC, Peruhype-Magalhães V, Coelho-Dos-Reis JG, Costa-Pereira C, Yamamura AY, Lima SMB, Simões M, Campos FMF, de Castro Zacche Tonini A, Lemos EM, Brum RC, de Noronha TG, Freire MS, Maia MLS, Camacho LAB, Rios M, Chancey C, Romano A, Domingues CM, Teixeira-Carvalho A, Martins-Filho OA; Collaborative Group for Studies of Yellow Fever Vaccine.

J Immunol Methods. 2017 Sep;448:9-20. doi: 10.1016/j.jim.2017.05.002. Epub 2017 May 14.

PMID:
28514646
14.

Flow cytometric-based protocols for assessing anti-MT-2 IgG1 reactivity: High-dimensional data handling to define predictors for clinical follow-up of Human T-cell Leukemia virus type-1 infection.

Coelho-Dos-Reis JG, Peruhype-Magalhães V, Pascoal-Xavier MA, de Souza Gomes M, do Amaral LR, Cardoso LM, Jonathan-Gonçalves J, Ribeiro ÁL, Starling AL, Ribas JG, Gonçalves DU, de Freitas Carneiro-Proietti AB, Teixeira-Carvalho A, Martins-Filho OA; GIPH.

J Immunol Methods. 2017 May;444:36-46. doi: 10.1016/j.jim.2017.02.006. Epub 2017 Feb 16.

PMID:
28212879
15.

Strategies for serum chemokine/cytokine assessment as biomarkers of therapeutic response in HCV patients as a prototype to monitor immunotherapy of infectious diseases.

Menezes EG, Coelho-Dos-Reis JG, Cardoso LM, Lopes-Ribeiro Á, Jonathan-Gonçalves J, Porto Gonçalves MT, Cambraia RD, Soares EB, Silva LD, Peruhype-Magalhães V, Rios M, Chancey C, Teixeira-Carvalho A, Martins-Filho OA, Teixeira R.

Antiviral Res. 2017 May;141:19-28. doi: 10.1016/j.antiviral.2017.02.001. Epub 2017 Feb 2.

16.

Lifewide profile of cytokine production by innate and adaptive immune cells from Brazilian individuals.

Silveira-Nunes G, Speziali E, Teixeira-Carvalho A, Vitelli-Avelar DM, Sathler-Avelar R, Figueiredo-Soares T, Silva ML, Peruhype-Magalhães V, Chaves DG, Brito-Melo GE, Cardoso GM, Soares EB, Elói-Santos SM, Teixeira R, Queiroz DM, Corrêa-Oliveira R, Faria AMC, Martins-Filho OA.

Immun Ageing. 2017 Jan 23;14:2. doi: 10.1186/s12979-017-0084-5. eCollection 2017.

17.

Acceptance and potential barriers to effective use of diagnostic tests for visceral leishmaniasis in an urban area in Brazil.

Assis TM, Guimarães PN, Oliveira E, Peruhype-Magalhães V, Gomes LI, Rabello A.

Rev Soc Bras Med Trop. 2016 Apr;49(2):241-4. doi: 10.1590/0037-8682-0247-2015.

18.

Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes.

Moreira ML, Costa-Pereira C, Alves ML, Marteleto BH, Ribeiro VM, Peruhype-Magalhães V, Giunchetti RC, Martins-Filho OA, Araújo MS.

Vet Parasitol. 2016 Apr 15;220:33-45. doi: 10.1016/j.vetpar.2016.02.009. Epub 2016 Feb 15.

PMID:
26995719
19.

Study of implementation and direct cost estimates for diagnostic tests for human visceral leishmaniasis in an urban area in Brazil.

Assis TS, Guimarães PN, Oliveira E, Peruhype-Magalhães V, Gomes LI, Rabello A.

Cad Saude Publica. 2015 Oct;31(10):2127-36. doi: 10.1590/0102-311X00158614.

20.

Immunological signature of the different clinical stages of the HTLV-1 infection: establishing serum biomarkers for HTLV-1-associated disease morbidity.

Starling AL, Coelho-Dos-Reis JG, Peruhype-Magalhães V, Pascoal-Xavier MA, Gonçalves DU, Béla SR, Lambertucci JR, Labanca L, Souza Pereira SR, Teixeira-Carvalho A, Ribas JG, Trindade BC, Faccioli LH, Carneiro-Proietti AB, Martins-Filho OA.

Biomarkers. 2015;20(6-7):502-12. doi: 10.3109/1354750X.2015.1094141. Epub 2015 Oct 16.

PMID:
26474234
21.

Booster dose after 10 years is recommended following 17DD-YF primary vaccination.

Campi-Azevedo AC, Costa-Pereira C, Antonelli LR, Fonseca CT, Teixeira-Carvalho A, Villela-Rezende G, Santos RA, Batista MA, Campos FM, Pacheco-Porto L, Melo Júnior OA, Hossell DM, Coelho-dos-Reis JG, Peruhype-Magalhães V, Costa-Silva MF, de Oliveira JG, Farias RH, Noronha TG, Lemos JA, von Doellinger Vdos R, Simões M, de Souza MM, Malaquias LC, Persi HR, Pereira JM, Martins JA, Dornelas-Ribeiro M, Vinhas Ade A, Alves TR, Maia Mde L, Freire Mda S, Martins Rde M, Homma A, Romano AP, Domingues CM, Tauil PL, Vasconcelos PF, Rios M, Caldas IR, Camacho LA, Martins-Filho OA.

Hum Vaccin Immunother. 2016;12(2):491-502. doi: 10.1080/21645515.2015.1082693.

22.

Divergent cerebrospinal fluid cytokine network induced by non-viral and different viral infections on the central nervous system.

Bastos MS, Coelho-Dos-Reis JG, Zauli DA, Naveca FG, Monte RL, Pimentel JP, Macário VM, da Silva NL, Peruhype-Magalhães V, Pascoal-Xavier MA, Guimaraes A, Carvalho AT, Malheiro A, Martins-Filho OA, Mourão MP.

BMC Infect Dis. 2015 Aug 19;15:345. doi: 10.1186/s12879-015-1035-4.

23.

RAP1 GTPase overexpression is associated with cervical intraepithelial neoplasia.

Pascoal-Xavier MA, Figueiredo AC, Gomes LI, Peruhype-Magalhães V, Calzavara-Silva CE, Costa MA, Reis IA, Bonjardim CA, Kroon EG, Oliveira JG, Ferreira PC.

PLoS One. 2015 Apr 9;10(4):e0123531. doi: 10.1371/journal.pone.0123531. eCollection 2015.

24.

Protective Profile Involving CD23/IgE-mediated NO Release is a Hallmark of Cutaneous Leishmaniasis Patients from the Xakriabá Indigenous Community in Minas Gerais, Brazil.

Carvalho-Gontijo R, Peruhype-Magalhães V, Costa-Silva MF, Martins-Filho OA, Quaresma PF, Freire Jde M, Moreno Ede C, Teixeira-Carvalho A, Gontijo CM.

Scand J Immunol. 2015 Jun;81(6):515-24. doi: 10.1111/sji.12294.

25.

Etiological treatment of Chagas disease patients with benznidazole lead to a sustained pro-inflammatory profile counterbalanced by modulatory events.

Campi-Azevedo AC, Gomes JA, Teixeira-Carvalho A, Silveira-Lemos D, Vitelli-Avelar DM, Sathler-Avelar R, Peruhype-Magalhães V, Béla SR, Silvestre KF, Batista MA, Schachnik NC, Correa-Oliveira R, Eloi-Santos SM, Martins-Filho OA.

Immunobiology. 2015 May;220(5):564-74. doi: 10.1016/j.imbio.2014.12.006. Epub 2015 Jan 8.

PMID:
25648688
26.

CD11c+CD123Low dendritic cell subset and the triad TNF-α/IL-17A/IFN-γ integrate mucosal and peripheral cellular responses in HIV patients with high-grade anal intraepithelial neoplasia: a systems biology approach.

Guimarães AG, da Costa AG, Martins-Filho OA, Pimentel JP, Zauli DA, Peruhype-Magalhães V, Teixeira-Carvalho A, Béla SR, Xavier MA, Coelho-Dos-Reis JG, Abranches JS, Guimarães JJ, Malheiro A, Ferreira LC.

J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):112-22. doi: 10.1097/QAI.0000000000000412.

PMID:
25590266
27.

Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline.

Campi-Azevedo AC, de Almeida Estevam P, Coelho-Dos-Reis JG, Peruhype-Magalhães V, Villela-Rezende G, Quaresma PF, Maia Mde L, Farias RH, Camacho LA, Freire Mda S, Galler R, Yamamura AM, Almeida LF, Lima SM, Nogueira RM, Silva Sá GR, Hokama DA, de Carvalho R, Freire RA, Filho EP, Leal Mda L, Homma A, Teixeira-Carvalho A, Martins RM, Martins-Filho OA.

BMC Infect Dis. 2014 Jul 15;14:391. doi: 10.1186/1471-2334-14-391.

28.

High prevalence of asymptomatic Leishmania spp. infection among liver transplant recipients and donors from an endemic area of Brazil.

Clemente WT, Rabello A, Faria LC, Peruhype-Magalhães V, Gomes LI, da Silva TA, Nunes RV, Iodith JB, Protil KZ, Fernandes HR, Cortes JR, Lima SS, Lima AS, Romanelli RM.

Am J Transplant. 2014 Jan;14(1):96-101. doi: 10.1111/ajt.12521.

29.

Gene expression profile of cytokines and chemokines in skin lesions from Brazilian Indians with localized cutaneous leishmaniasis.

Costa-Silva MF, Gomes LI, Martins-Filho OA, Rodrigues-Silva R, Freire Jde M, Quaresma PF, Pascoal-Xavier MA, Mendes TA, Serakides R, Zauli DA, Campi-Azevedo AC, Melo MN, Gontijo CM, Peruhype-Magalhães V, Teixeira-Carvalho A.

Mol Immunol. 2014 Feb;57(2):74-85. doi: 10.1016/j.molimm.2013.08.008. Epub 2013 Sep 28.

PMID:
24084096
30.

Dual role of IL-12 in the therapeutic efficacy or failure during combined PEG-Interferon-α2A and ribavirin therapy in patients with chronic hepatitis C.

Araújo AR, Peruhype-Magalhães V, Coelho-dos-Reis JG, Chaves LP, de Lima TA, Pimentel JP, de Paula L, de Almeida CM, Tarragô AM, Tateno A, Levi JE, Teixeira-Carvalho A, Martins-Filho OA, Lira Eda F, Torres KL, Talhari S, Malheiro A.

Immunol Lett. 2013 Jul-Aug;154(1-2):61-9. doi: 10.1016/j.imlet.2013.07.010. Epub 2013 Aug 21.

PMID:
23973662
31.

Immunological profile of HTLV-1-infected patients associated with infectious or autoimmune dermatological disorders.

Coelho-dos-Reis JG, Passos L, Duarte MC, Araújo MG, Campi-Azevedo AC, Teixeira-Carvalho A, Peruhype-Magalhães V, Trindade BC, Dos Santos Dias R, Martins ML, Carneiro-Proietti AB, Guedes AC, Gonçalves DU, Martins-Filho OA.

PLoS Negl Trop Dis. 2013 Jul 25;7(7):e2328. doi: 10.1371/journal.pntd.0002328. Print 2013.

32.

Use of the Kala-Azar Detect® and IT-LEISH® rapid tests for the diagnosis of visceral leishmaniasis in Brazil.

Peruhype-Magalhães V, Machado-de-Assis TS, Rabello A.

Mem Inst Oswaldo Cruz. 2012 Nov;107(7):951-2.

33.

Distinct pattern of immunophenotypic features of innate and adaptive immunity as a putative signature of clinical and laboratorial status of patients with localized cutaneous leishmaniasis.

Freitas-Teixeira PM, Silveira-Lemos D, Giunchetti RC, Baratta-Masini A, Mayrink W, Peruhype-Magalhães V, Rocha RD, Campi-Azevedo AC, Teixeira-Carvalho A, Martins-Filho OA.

Scand J Immunol. 2012 Oct;76(4):421-32. doi: 10.1111/j.1365-3083.2012.02748.x.

34.

Impaired phagocytic capacity driven by downregulation of major phagocytosis-related cell surface molecules elicits an overall modulatory cytokine profile in neutrophils and monocytes from the indeterminate clinical form of Chagas disease.

Gomes JA, Campi-Azevedo AC, Teixeira-Carvalho A, Silveira-Lemos D, Vitelli-Avelar D, Sathler-Avelar R, Peruhype-Magalhães V, Silvestre KF, Batista MA, Schachnik NC, Correa-Oliveira R, Eloi-Santos S, Martins-Filho OA.

Immunobiology. 2012 Oct;217(10):1005-16. doi: 10.1016/j.imbio.2012.01.014. Epub 2012 Jan 20.

PMID:
22387073
35.

Applicability of an optimized non-conventional flow cytometry method to detect anti-Trypanosoma cruzi immunoglobulin G for the serological diagnosis and cure assessment following chemotherapeutic treatment of Chagas disease.

Matos CS, Coelho-Dos-Reis JG, Rassi A, Luquetti AO, Dias JC, Eloi-Santos SM, Gomes IT, Vitelli-Avelar DM, Wendling AP, Rocha RD, Teixeira-Carvalho A, Peruhype-Magalhães V, Andrade MC, Martins-Filho OA.

J Immunol Methods. 2011 Jun 30;369(1-2):22-32. doi: 10.1016/j.jim.2011.03.007. Epub 2011 Apr 6.

PMID:
21477591
36.

Immunological/virological peripheral blood biomarkers and distinct patterns of sleeping quality in chronic hepatitis C patients.

de Almeida CM, de Lima TA, Castro DB, Torres KL, da Silva Braga W, Peruhype-Magalhães V, Teixeira-Carvalho A, Martins-Filho OA, Malheiro A.

Scand J Immunol. 2011 May;73(5):486-95. doi: 10.1111/j.1365-3083.2011.02518.x.

37.

Anti-Leishmania chagasi immunoglobulin G3 detected by flow cytometry for early cure assessment in American visceral leishmaniasis.

Gomes IT, Carvalho SF, Rocha RD, Peruhype-Magalhães V, Dietze R, Martins-Filho OA, Lemos EM.

J Immunol Methods. 2010 Aug 31;360(1-2):76-83. doi: 10.1016/j.jim.2010.06.011. Epub 2010 Jun 17.

PMID:
20598707
38.

Clinical and immunological insights on severe, adverse neurotropic and viscerotropic disease following 17D yellow fever vaccination.

Silva ML, Espírito-Santo LR, Martins MA, Silveira-Lemos D, Peruhype-Magalhães V, Caminha RC, de Andrade Maranhão-Filho P, Auxiliadora-Martins M, de Menezes Martins R, Galler R, da Silva Freire M, Marcovistz R, Homma A, Teuwen DE, Elói-Santos SM, Andrade MC, Teixeira-Carvalho A, Martins-Filho OA.

Clin Vaccine Immunol. 2010 Jan;17(1):118-26. doi: 10.1128/CVI.00369-09. Epub 2009 Nov 11.

39.

Anti-fixed Leishmania chagasi promastigotes IgG antibodies detected by flow cytometry (FC-AFPA-IgG) as a tool for serodiagnosis and for post-therapeutic cure assessment in American visceral leishmaniasis.

Garcia LM, Coelho-Dos-Reis JG, Peruhype-Magalhães V, Teixeira-Carvalho A, Rocha RD, Araújo MS, Gomes IT, Carvalho SF, Dietze R, Lemos EM, Andrade MC, Martins-Filho OA.

J Immunol Methods. 2009 Oct 31;350(1-2):36-45. doi: 10.1016/j.jim.2009.07.004. Epub 2009 Jul 25.

PMID:
19635482
40.

Intracellular nitric oxide assessment in whole blood leukocytes by flow cytometry: optimization and applicability to monitor patients with chronic graft nephropathy.

Schachnik NC, Peruhype-Magalhães V, Paula GM, Lucas F Jr, Freitas VM, Martins-Filho OA, Dusse LM.

J Immunol Methods. 2009 Apr 15;343(2):103-11.

PMID:
19374002
41.

Variation rhythms of lymphocyte subsets during healthy aging.

Faria AM, de Moraes SM, de Freitas LH, Speziali E, Soares TF, Figueiredo-Neves SP, Vitelli-Avelar DM, Martins MA, Barbosa KV, Soares EB, Sathler-Avelar R, Peruhype-Magalhães V, Cardoso GM, Comin F, Teixeira R, Elói-Santos SM, Queiroz DM, Corrêa-Oliveira R, Bauer ME, Teixeira-Carvalho A, Martins-Filho OA.

Neuroimmunomodulation. 2008;15(4-6):365-79. doi: 10.1159/000156478. Epub 2008 Nov 26.

PMID:
19047812
42.

HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network.

Goncalves DU, Proietti FA, Barbosa-Stancioli EF, Martins ML, Ribas JG, Martins-Filho OA, Teixeira-Carvalho A, Peruhype-Magalhães V, Carneiro-Proietti AB.

Inflamm Allergy Drug Targets. 2008 Jun;7(2):98-107. Review.

PMID:
18691139
43.

Upgrading the flow-cytometric analysis of anti-Leishmania immunoglobulins for the diagnosis of American tegumentary leishmaniasis.

Pissinate JF, Gomes IT, Peruhype-Magalhães V, Dietze R, Martins-Filho OA, Lemos EM.

J Immunol Methods. 2008 Jul 31;336(2):193-202. doi: 10.1016/j.jim.2008.04.018. Epub 2008 May 21.

PMID:
18538785
44.

Cytokines, chemokine receptors, CD4+CD25HIGH+ T-cells and clinical forms of human schistosomiasis.

Teixeira-Carvalho A, Martins-Filho OA, Peruhype-Magalhães V, Silveira-Lemos D, Malaquias LC, Oliveira LF, Silveira AM, Gazzinelli A, Gazzinelli G, Corrêa-Oliveira R.

Acta Trop. 2008 Nov-Dec;108(2-3):139-49. doi: 10.1016/j.actatropica.2008.04.010. Epub 2008 Apr 18.

PMID:
18534548
45.

Combined diagnostic methods identify a remarkable proportion of asymptomatic Leishmania (Leishmania) chagasi carriers who present modulated cytokine profiles.

de Gouvêa Viana L, de Assis TS, Orsini M, da Silva AR, de Souza GF, Caligiorne R, da Silva AC, Peruhype-Magalhães V, Marciano AP, Martins-Filho OA, Rabello A.

Trans R Soc Trop Med Hyg. 2008 Jun;102(6):548-55. doi: 10.1016/j.trstmh.2008.02.007. Epub 2008 Mar 25.

PMID:
18367221
46.

Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination.

Martins MA, Silva ML, Elói-Santos SM, Ribeiro JG, Peruhype-Magalhães V, Marciano AP, Homma A, Kroon EG, Teixeira-Carvalho A, Martins-Filho OA.

Vaccine. 2008 Feb 26;26(9):1173-84. doi: 10.1016/j.vaccine.2007.12.035. Epub 2008 Jan 14.

PMID:
18243433
47.

Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?

Martins MA, Silva ML, Marciano AP, Peruhype-Magalhães V, Eloi-Santos SM, Ribeiro jG, Correa-Oliveira R, Homma A, Kroon EG, Teixeira-Carvalho A, Martins-Filho OA.

Clin Exp Immunol. 2007 Apr;148(1):90-100.

48.

IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection.

Brito-Melo GE, Peruhype-Magalhães V, Teixeira-Carvalho A, Barbosa-Stancioli EF, Carneiro-Proietti AB, Catalan-Soares B, Ribas JG; Grupo Interdisciplinar de Pesquisas sobre HTLV (GIPH), Martins-Filho OA.

Clin Exp Immunol. 2007 Jan;147(1):35-44.

49.

Mixed inflammatory/regulatory cytokine profile marked by simultaneous raise of interferon-gamma and interleukin-10 and low frequency of tumour necrosis factor-alpha(+) monocytes are hallmarks of active human visceral Leishmaniasis due to Leishmania chagasi infection.

Peruhype-Magalhães V, Martins-Filho OA, Prata A, Silva Lde A, Rabello A, Teixeira-Carvalho A, Figueiredo RM, Guimarães-Carvalho SF, Ferrari TC, Van Weyenbergh J, Correa-Oliveira R.

Clin Exp Immunol. 2006 Oct;146(1):124-32.

50.

Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome.

Peruhype-Magalhães V, Martins-Filho OA, Prata A, Silva Lde A, Rabello A, Teixeira-Carvalho A, Figueiredo RM, Guimarães-Carvalho SF, Ferrari TC, Correa-Oliveira R.

Scand J Immunol. 2005 Nov;62(5):487-95.

Supplemental Content

Loading ...
Support Center